REN and Hepatic fibrosis: A study based on a rat model of hepatic fibrosis induced by dimethylnitrosamine (DMN) demonstrated the potential of swertiamarin as a treatment for hepatic fibrosis by targeting the renin-angiotensin system (RAS).